Advanced Bionics (AB), a leading force in cochlear implant technology, recently received FDA approval for its expanded Marvel CI product line. This expansion aims to revolutionize hearing care delivery and significantly improve patient outcomes. The new offerings bring remarkable advancements to the field:

Firstly, AB introduces the Remote Support app, allowing users to remotely access and program their Marvel CI sound processor via their smartphone. This breakthrough technology facilitates virtual consultations and adjustments with hearing care professionals (HCPs), eliminating the need for patients to undertake long journeys to clinics. It ensures more accessible and timely care for individuals with cochlear implants.

Secondly, in collaboration with sister company Phonak, AB introduces linked two-ear solutions, enhancing sound localization and improving hearing in noisy environments. Notably, Marvel CI stands out as the sole CI system integrated with a CROS device, providing users with a more comprehensive auditory experience. This innovation promises a significant advancement for individuals with severe to profound hearing loss in both ears.

Additionally, AB unveils Target CI Version 1.5, an upgraded programming software designed for enhanced efficiency in managing cochlear implants and hearing instruments. This version now supports the programming and configuration of the Phonak CROS device, empowering professionals to cater to their patients' needs more effectively.

These innovations mark a significant leap forward in making hearing healthcare more accessible, convenient, and comprehensive for individuals relying on cochlear implants. AB's advancements promise a new era of improved accessibility and patient-centered care in the field of auditory health.

Source: businesswire.com

Report Abuse